Mohamad E. Allaf, MD
Consider Neoadjuvant, Adjuvant Targeted Therapy for RCC
Neoadjuvant targeted therapy for renal cell carcinoma is less toxic than adjuvant targeted therapy, but both should ...
AUGUST 9, 2017
Load more